PharmaNet

inVentiv Health Clinical acquires equity stake in Mytrus

Wednesday, March 13, 2013 12:35 PM

inVentiv Health, based in Burlington, Mass., has taken an equity stake in Mytrus, a pioneer in virtual clinical trials and technologies including electronic informed consent to improve trial efficiency.

More... »

PharmaNet/i3 renamed inVentiv Health Clinical

Wednesday, January 30, 2013 11:07 AM

inVentiv Health,  a global provider of clinical, commercial and consulting services, announced that its existing CRO, PharmaNet/i3, will be renamed inVentiv Health Clinical. This renaming reflects the closer alignment between the clinical segment and inVentiv's commercial and consulting services.

More... »

Stansfield joins PharmaNet/i3 as executive vice president, clinical operations

Wednesday, December 19, 2012 11:39 AM

PharmaNet/i3, inVentiv Health’s clinical segment and a provider of clinical development services, has appointed Dr. Susan C. Stansfield as executive vice president of clinical operations for phase II-IV development in Europe, Middle East and Africa (EMEA), Asia-Pacific and Latin America. 

More... »

Hantash joins PharmaNet/i3

Friday, October 12, 2012 02:06 PM

PharmaNet/i3, inVentiv Health’s clinical segment and a provider of clinical development services, has appointed Jamil Hantash, MSc, M.B.A., as director of Immunochemistry Operations at PharmaNet/i3’s Princeton, N.J., bioanalytical laboratory. 

More... »

Quanticate adds new leadership to oversee expansion

Thursday, July 26, 2012 03:51 PM

Quanticate, a global data-focused clinical CRO, has appointed Sally Du Toit as vice president of pharmacovigilance and Chris Cramer as vice president of clinical data management.  

More... »

PharmaNet/i3 names VP and general manager, neuroscience

Monday, July 16, 2012 11:05 AM

PharmaNet/i3, inVentiv Health’s clinical segment, has appointed Robert Lasser, M.D., MBA, vice president and general manager, neuroscience, overseeing the management of all clinical projects handled by PharmaNet/i3’s neuroscience group and the Rater Training Services team. Dr. Lasser will be based in Princeton, N.J.

More... »

PharmaNet/i3 introduces PharmaNet/i3 Strategic Resourcing

Thursday, June 28, 2012 11:46 AM

PharmaNet/i3, inVentiv Health’s clinical segment and provider of clinical development services, has launched PharmaNet/i3 Strategic Resourcing, a new unified provider of staffing and functional service provider (FSP) services.

More... »

ACT Oncology names Julia Amo as COO

Wednesday, March 28, 2012 12:02 PM

ACT Oncology, a niche oncology service provider, has appointed Julia Amo, MBA, PMP, as chief operating officer.

More... »

ASLAN selects PharmaNet/i3 as strategic partner for oncology development

Tuesday, March 6, 2012 01:30 PM

ASLAN Pharmaceuticals has selected PharmaNet/i3, inVentiv Health’s clinical segment, as a strategic partner supporting the development of its oncology portfolio in Asia and conducting phase I and phase II clinical trials for two of ASLAN’s compounds.

More... »

Stephan Henauer to head i3 Pharma Resourcing in Europe

Monday, February 6, 2012 02:52 PM

PharmaNet/i3, inVentiv Health’s clinical segment, has appointed Stephan Henauer, M.D., executive director of i3 Pharma Resourcing. Henauer will lead the company’s staffing business in central, eastern and northern Europe.

More... »